Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFB | P00751 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.45 |
| ▸ | CRHBP | P24387 | 1/20 | 0.45 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.45 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10211060 | 0.98 | CFB (0.50) | CFBALDH1A1KDM4EHRH3CYP2D6 | |
| SCHEMBL20196154 | 0.87 | KDM4E (0.60) | CFBALDH1A1KDM4EHRH3CYP2D6 | |
| SCHEMBL17857251 | 0.85 | KDM4E (0.55) | CFBALDH1A1KDM4EHRH3CYP2D6 | |
| SCHEMBL807423 | 0.85 | ALDH1A1 (0.51) | CFBALDH1A1KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL11211349 | 0.83 | CYP2D6 (0.51) | CFBALDH1A1KDM4EHRH3CYP2D6 | |
| SCHEMBL29253343 | 0.83 | CFB (0.43) | CFBALDH1A1KDM4EHRH3CYP2D6 | |
| SCHEMBL10102493 | 0.82 | KMT2A (0.65) | ALDH1A1KDM4ESMN1; SMN2TDP1MEN1 | |
| SCHEMBL18713208 | 0.82 | MC4R (0.55) | ALDH1A1KDM4ETDP1KMT2ACHRNA7 | |
| SCHEMBL10702627 | 0.80 | COMT (0.47) | CFBALDH1A1KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL918507 | 0.80 | KMT2A (0.41) | CFBALDH1A1KDM4EPOLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117720721-B | Anion exchange polymer, ion exchange membrane, and preparation methods and application thereof | 国家电投集团氢能科技发展有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117720721-A | Anion exchange polymer, ion exchange membrane, and preparation methods and application thereof | 国家电投集团氢能科技发展有限公司 | 2024-03-19 | — | — | CN | disclosed |
| US-20230321067-A1 | DOSING REGIMEN COMPRISING 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. | 2023-10-12 | — | — | US | disclosed |
| EP-3594202-B1 | SUBSTITUTED PYRROLIDINE COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICALS CO (JP) | 2021-08-11 | — | — | EP | disclosed |
| EP-2615916-B1 | FUSED PYRAZOLE DERIVATIVES AS NOVEL ERK INHIBITORS | MERCK SHARP & DOHME (US) | 2017-01-04 | — | — | EP | disclosed |
| WO-2012036997-A1 | FUSED PYRAZOLE DERIVATIVES AS NOVEL ERK INHIBITORS | SCHERING CORPORATION (US) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230321067-A1 | DOSING REGIMEN COMPRISING 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES | IKZF1, IKZF2, IKZF3 | CFB 4693/4885ALDH1A1 2551/4885KDM4E 335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.